BPA Call HHSN263201500214B-HHSN26400003
- Not listed
- Integrated DNA Technologies, Inc. (IDT), a leading manufacturer of specialized nucleic acid products headquartered in Coralville, Iowa, received a Blanket Purchase Agreement (BPA) call award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) for gene synthesis and DNA custom sequencing services. The contract, valued at $11,754.88, was awarded on August 22, 2017, with an ultimate completion date of August 23, 2018, under firm fixed-price terms. This BPA call...
- Integrated DNA Technologies, Inc. (IDT), a leading manufacturer of specialized nucleic acid products headquartered in Coralville, Iowa, received a $10,000 Blanket Purchase Agreement (BPA) call award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on July 16, 2014. The contract, which was awarded without a set-aside designation, is structured as a firm fixed-price procurement with a completion date of May 31, 2015, and performance to be executed in Bethesda,...
- This federal contract award was made by the Office of the Chief Operating Officer, a civilian agency, to Integrated DNA Technologies, Inc. (IDT), a leading manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government. The $3,360 firm fixed-price contract, awarded on January 22, 2015, is a Blanket Purchase Agreement (BPA) call with a completion date of January 30, 2015. IDT, a for-profit organization headquartered in Coralville, Iowa, has a strong...
- Integrated DNA Technologies, Inc. (IDT), headquartered in Coralville, Iowa, was awarded a $19,858 Blanket Purchase Agreement (BPA) call by the National Institute of Environmental Health Sciences (NIEH), a civilian agency within the National Institutes of Health. This firm-fixed-price contract, awarded on August 31, 2022, with an ultimate completion date of August 31, 2023, represents a call against an existing BPA vehicle. The contract carries no set-aside designation, reflecting IDT's...
- This federal contract award to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH). The $58,670.92 firm-fixed-price contract is for the delivery of oligonucleotides, which are short DNA or RNA sequences used in a variety of biomedical research and clinical applications. IDT has a broader $100,000,000...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT). The contract, valued at $38,267.40, is a firm-fixed-price BPA Call to provide various oligonucleotide synthesis and related laboratory supplies and services. IDT, a leading manufacturer of specialized nucleic acid products, supports numerous federal agencies through both prime contracts and...
- Integrated DNA Technologies, Inc. (IDT), headquartered in Coralville, Iowa, received a Blanket Purchase Agreement (BPA) call award from the National Institute of Neurological Disorders and Stroke (NINDS) on August 17, 2022, with a ceiling value of $13,406.24. This Firm Fixed Price contract is for antisense oligonucleotide (ASO) products and was completed by May 31, 2023. The award was made without a set-aside designation, demonstrating IDT's competitive standing in open market procurements....
- Integrated DNA Technologies, Inc. (IDT) received a firm fixed-price Blanket Purchase Agreement (BPA) call award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases for custom minigene vectors, with a ceiling value of $11,267.20. The award, issued on May 29, 2018, with an ultimate completion date of August 31, 2018, does not utilize a set-aside designation. Performance will take place at IDT's headquarters in Coralville, Iowa. This BPA call represents a task order...
- This is a firm fixed-price contract awarded by the National Heart Lung and Blood Institute, an agency of the Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides needed to support an antibody association study project. The $16,494.25 contract is a Blanket Purchase Agreement (BPA) call and does not utilize any set-aside designations, indicating IDT competed effectively in the open market. IDT is a leading manufacturer and supplier of...
- Integrated DNA Technologies, Inc. (IDT) has been awarded a firm fixed price purchase order totaling $101,976 by the National Institutes of Health National Heart Lung and Blood Institute to supply reagents for the sequencing of bone marrow failure syndromes. IDT will deliver the requested products from its place of performance in Coralville, Iowa in support of the agency's research into these conditions. No set-aside designation was applied to this procurement. IDT has an established record of...
- HHSN263201500214BBlanket Purchase Agreement
- HHSN263201500214B-HHSN26400003BPA Call
Integrated DNA Technologies, Inc. (IDT), headquartered in Coralville, Iowa, received a contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) for custom oligonucleotides valued at $14,638.50. Issued on March 24, 2016, this Blanket Purchase Agreement (BPA) call was awarded on a firm fixed-price basis with an ultimate completion date of August 31, 2016. The contract was not designated as a set-aside procurement, indicating IDT competed in an open market environment. Work will be performed at IDT's facility in Coralville, Iowa. IDT is a leading manufacturer of specialized nucleic acid products including custom DNA and RNA oligonucleotides, gene fragments, and sequencing products that support federal biomedical research initiatives. The company maintains an established presence across multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense, and holds significant indefinite delivery vehicles including a $5 million BPA with the Defense Health Agency and a $10 million BPA with the National Institute of Neurological Disorders and Stroke. This NIAMS award exemplifies IDT's ongoing role as a critical commercial supplier of high-precision molecular biology reagents and materials for federal research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.6k | 3/24/16 |